Who
Jeremy B. Hayden
Chief Legal Officer
Company insider
Files Form 4 as: Chief Legal Officer, Sight Sciences; General Counsel, Endologix Inc /de/; General Counsel & VP of BD, Cerenome.
In numbers
- Trades disclosed
- 58
- Buys
- 2
- Sells
- 17
- Bought
- $9,972
- Sold
- $1.1M
- Companies
- 3
- Companies where not an officer
- 0
- First trade
- 10 Aug 2015
- Last trade
- 6 Jul 2026
- Last filed
- 6 Jul 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 6 Jul 2026filed 6 Jul 2026 | SGHT Sight SciencesMedical Devices | SEC FORM 4 Sold | $70K12,733 at $5.51 | filing |
| 6 Jul 2026filed 6 Jul 2026 | SGHT Sight SciencesMedical Devices | SEC FORM 4 Sold | $70K12,733 at $5.51 | filing |
| 6 Apr 2026filed 9 Apr 2026 | SGHT Sight SciencesMedical Devices | SEC FORM 4 Sold | $49K13,761 at $3.55 | filing |
| 6 Apr 2026filed 9 Apr 2026 | SGHT Sight SciencesMedical Devices | SEC FORM 4 Sold | $49K13,761 at $3.55 | filing |
| 3 Feb 2026filed 5 Feb 2026 | SGHT Sight SciencesMedical Devices | SEC FORM 4 Code A | —115,920 at $0.00 | filing |
| 3 Feb 2026filed 5 Feb 2026 | SGHT Sight SciencesMedical Devices | SEC FORM 4 Code A | —115,920 at $0.00 | filing |
| 16 Jan 2026filed 21 Jan 2026 | SGHT Sight SciencesMedical Devices | SEC FORM 4 Sold | $42K6,308 at $6.62 | filing |
| 16 Jan 2026filed 21 Jan 2026 | SGHT Sight SciencesMedical Devices | SEC FORM 4 Sold | $42K6,308 at $6.62 | filing |
| 6 Jan 2026filed 6 Jan 2026 | SGHT Sight SciencesMedical Devices | SEC FORM 4 Sold | $13K1,785 at $7.48 | filing |
| 6 Jan 2026filed 6 Jan 2026 | SGHT Sight SciencesMedical Devices | SEC FORM 4 Sold | $13K1,785 at $7.48 | filing |
| 5 Jan 2026filed 6 Jan 2026 | SGHT Sight SciencesMedical Devices | SEC FORM 4 Sold | $73K9,385 at $7.82 | filing |
| 5 Jan 2026filed 6 Jan 2026 | SGHT Sight SciencesMedical Devices | SEC FORM 4 Sold | $73K9,385 at $7.82 | filing |
| 25 Nov 2025filed 26 Nov 2025 | SGHT Sight Sciencesoption or derivative · Medical Devices | SEC FORM 4 Code M | —37,560 at $0.00 | filing |
| 25 Nov 2025filed 26 Nov 2025 | SGHT Sight Sciencesoption or derivative · Medical Devices | SEC FORM 4 Code M | —7,290 at $0.00 | filing |
| 25 Nov 2025filed 26 Nov 2025 | SGHT Sight SciencesMedical Devices | SEC FORM 4 Code M | $74K37,560 at $1.96 | filing |
| 25 Nov 2025filed 26 Nov 2025 | SGHT Sight SciencesMedical Devices | SEC FORM 4 Code M | $14K7,290 at $1.96 | filing |
| 25 Nov 2025filed 26 Nov 2025 | SGHT Sight SciencesMedical Devices | SEC FORM 4 Sold | $362K44,850 at $8.08 | filing |
| 12 Nov 2025filed 14 Nov 2025 | SGHT Sight Sciencesoption or derivative · Medical Devices | SEC FORM 4 Code M | —2,440 at $0.00 | filing |
| 12 Nov 2025filed 14 Nov 2025 | SGHT Sight Sciencesoption or derivative · Medical Devices | SEC FORM 4 Code M | —710 at $0.00 | filing |
| 12 Nov 2025filed 14 Nov 2025 | SGHT Sight SciencesMedical Devices | SEC FORM 4 Code M | $4,7822,440 at $1.96 | filing |
News
Insider Selling: Sight Sciences (NASDAQ:SGHT) CTO Sells $70,562.85 in StockSGHT · themarketsdaily.com · 8 Oct 2026Financial Contrast: Nano-X Imaging (NASDAQ:NNOX) & Sight Sciences (NASDAQ:SGHT)SGHT · themarketsdaily.com · 8 Oct 2026
0 headlines in the last 90 days name Jeremy B. Hayden; 2 articles from the last 14 days about the 1 company they traded most, at most three about any one of them.